seed
Stage
1
Investors
About
Madorra develops a non-hormonal, noninvasive medical device to treat vulvovaginal atrophy (vaginal dryness) in post-menopausal people and breast cancer survivors. The company has received FDA breakthrough device designation for the treatment of moderate to severe vulvovaginal atrophy.
Explore Madorra's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.